As per Globe & Mail: Boston Scientific fell 3.3 per cent to $18.18 after the U.S. Centers for Medicare and Medicaid Services proposed limited reimbursement coverage for a type of heart device, including the company’s recently approved Watchman device.
To drop it pre market that much with no news and sell it off like this is market #$%$ market makers trying to get small investors shares...im sure they succeded today..hopefully this is it but it might go lower before its nice run up...
My message didn't post properly, so I'll try again:
Maybe something else, but if purchase of CeloNova assets for $70 million up-front payment (less than 0.3% of BSX market cap) is the cause of the 4% loss in market cap in pre-market, then BSX is going to rebound strong today.
Maybe something else, but if purchase of CeloNova assets for $70 million up-front payment ( 4% loss in market cap in pre-market, then BSX is going to rebound strong today.
Surprise! FBEC is the next stock to possibly double our triple. Make sure FBEC is at the top of your watchlist because this one could go viral. They make hemp energy shots!
Harry has posted Charts of the Day video on BSX at TheTechTrader site noting: Boston Scientific Corporation (BSX) was up 27 cents to 18.94, or 1.45%, on 9.9 million shares. It took out resistance at the 18.94 level, consolidated, and moved up a small percentage, but it’s making new, multi-year highs. The targets are 21 1/2, followed by 25, and 27.
BSX couldn?t be more shamefully low if it tried; what a terrible play! I managed to salvage something by playing Ultimate Stock Alerts (you can find them in Google)
I haven?t seen a play has bad as BSX in years. I am now back on track since getting my alerts from Ultimate Stock Alerts (you can find them in Google)